2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceKey expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“If thoracic aortic disease can be detected early and managed, it gives us the opportunity to select patients for surgical or endovascular repair when the patient is stable. The results of treatment for stable disease are far better than for acute—and often catastrophic—aortic rupture or dissection.”
“We now have a deeper understanding of the genetic underpinnings of TAD, and we continue to expand our knowledge in this area. There have been rapid advances in noninvasive imaging. Medical therapy is much better. Open surgical techniques with anesthesia have improved dramatically. We can even use endovascular (minimally invasive, catheter-based) approaches in some patients.”
“Recently, the professional societies have felt that the guidelines that are of most value to our practitioners are those that are more diseased-focused. TAD is not an uncommon killer of Americans--it's in the top 20--and on the rise in our society, so it represents a significant opportunity to focus on this important problem.”
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Hiratzka et al. (2010) studied this question.